ESTUDIO COMPARATIVO DE LA ACTIVIDAD PSICOACTIVA DE PASSIFLORAS DE LA PROVINCIA DE CHIMBORAZO

Diego Vinueza; Gisela Pilco; Karen Acosta; Patricia Tierra; Patricio Noboa; Susana Abdo

doi:10.47187/perf.v1i19.20

Authors

Diego Vinueza Faculty of Science, Escuela Superior Politécnica de Chimborazo
Gisela Pilco Faculty of Science, Escuela Superior Politécnica de Chimborazo
Karen Acosta Faculty of Science, Escuela Superior Politécnica de Chimborazo
Patricia Tierra Faculty of Natural Resources, Escuela Superior Politécnica de Chimborazo
Patricio Noboa Faculty of Natural Resources, Escuela Superior Politécnica de Chimborazo
Susana Abdo Faculty of Science, Escuela Superior Politécnica de Chimborazo

DOI:

https://doi.org/10.47187/perf.v1i19.20

Keywords:

Passiflora, anxiolytic, flavonoids, elevated cross maze

Abstract

Climate variability and territorial location of Ecuador promotes biodiversity in the country. However, due to the presence of a big number of flora and fauna per square kilometer, most of it is not studied and despite not having a scientific argument for the use of some species, the population uses many of these for different pathologies, for this reason, a pharmacological study of six species of the genus Passiflora from the province of Chimborazo – Ecuador was carried out, traditionally used to treat nervousness. For identification, a thin layer chromatography profile of each species was carried out, of which it was possible to determine considerable quantities of molecules with grouping of flavonoid type and quantification of the total flavonoids. Of all the species P. manicata was noted for its high content of total flavonoids using aluminum chloride method for derivatizing the compounds of interest and to evaluate UV-visible spectrophotometry. While for the pharmacological activity it was carried out in vivo by the elevated plus-maze test. From the results obtained it has been determined that at least two of the six species have significant anxiolytic activity at doses of 25 and 50 mg/kg of hydroalcoholic extract. Species like P. edulis and P. mixta have bioactive constituents for this purpose.

Downloads

Download data is not yet available.

References

Ministerio del Ambiente del Ecuador. 2015. Quinto informe nacional para el convenio sobre la diversidad biológica. Quito - Ecuador. 36-38.

Ministerio del Ambiente del Ecuador. 2008. Revisión del avance y situación actual del Patrimonio de Áreas Naturales Protegidas del Ecuador (PANE). Quito - Ecuador. 56-72.

Jørgensen PM, León-Yañes S. 1999. Catalogue of the Vascular Plants of Ecuador. Missouri Botanical Garden Press. 779-783.

Escobar LK. Passifloraceae. 1988. In: Flora de Colombia. Instituto de Ciencias Naturales Universidad Nacional de Colombia; 138.

Hernández A, Bernal R. 2000. Lista de especies de Passifloraceae de Colombia. Biota Colomb. 1 Suppl 3:320–35.

Kinghorn GR. Passion, stigma, and STI. 2001. Sex Transm Infect. 77 Suppl 5:370

Miroddi M, Calapai G, Navarra M, Minciullo PL, Gangemi S. 2013. Passiflora incarnata L. Ethnopharmacology, clinical application, safety and evaluation of clinical trials. J Ethnopharmacol. 150 Suppl 3:791–804.

Matsui Y, Sugiyama K, Kamei M, Takahashi T, Suzuki T, Katagata Y, et al. 2010. Extract of Passion Fruit (Passiflora edulis) Seed Containing High Amounts of Piceatannol Inhibits Melanogenesis and Promotes Collagen Synthesis. J Agric Food Chem. 50 Suppl 20:11112–8.

Dhawan K, Dhawan S, Sharma A. 2004. Passiflora: A review update. J Ethnopharmacol. 94 Suppl 1:1–23.

Petry RD, Reginatto F, De-Paris F, Gosmann G, Salgueiro JB, Quevedo J, et al. 2001. Comparative pharmacological study of hydroethanol extracts of Passiflora alata and Passiflora edulis leaves. Phyther Res. 15 Suppl 2:162–4.

Dhawan K, Kumar S, Sharma A. 2001. Comparative biological activity study on Passiflora incarnata and P. edulis. Fitoterapia. 72 Suppl 6:698–702.

Gazola AC, Costa GM, Castellanos L, Ramos F a., Reginatto FH, Lima TCM De, et al. 2015. Involvement of GABAergic pathway in the sedative activity of apigenin, the main flavonoid from Passiflora quadrangularis pericarp. Rev Bras Farmacogn. 25 Suppl 2:158–63.

Wagner H, Bladt S. 2001. Plant Drug Analysis: A Thin Layer Chromatography Atlas. Analytica Chimica Acta. 383.

Boukhris M, Simmonds MSJ, Sayadi S, Bouaziz M. 2013. Chemical Composition and Biological Activities of Polar Extracts and Essential Oil of Rose-scented Geranium, Pelargonium graveolens. Phyther Res. 1206–1213.

Cardoso Vilela F, Soncini R, Giusti-Paiva A. 2009. Anxiolytic-like effect of Sonchus oleraceus L. in mice. J Ethnopharmacol. 124 Suppl 2:325–7.

Vogel HG. Drug Discovery and Evaluation: Pharmacological Assays. Vol 1. 3era ed; 2008.

Akindele A, Adeyemi O. 2010. Anxiolytic and sedative effects of Byrsocarpus coccineus Schum. And Thonn. Connaraceae) extract. Int J Appl Res Nat Prod. 3 Suppl 1:28–36.

Kennedy DO Do, Wightman EEL. 2011. Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function. Adv Nutr A 2:32–50.

Wink M. 2003. Evolution of secondary metabolites from an ecological and molecular phylogenetic perspective. Phytochemistry. 64 Suppl 3:19.

Miller A, Heyland A. 2010. Endocrine interactions between plants and animals: Implications of exogenous hormone sources for the evolution of hormone signaling. Gen Comp Endocrinol. 455–61.

Wolfman C, Viola H, Paladini A, Dajas F, Medina JH. 1994. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora Coerulea. Pharmacol Biochem Behav. 1 Suppl 47:1–4.

Da Silva Morrone M, De Assis AM, Da Rocha RF, Gasparotto J, Gazola AC, Costa GM, et al. 2013. Passiflora manicata (Juss.) aqueous leaf extract protects against reactive oxygen species and protein glycation in vitro and ex vivo models. Food Chem Toxicol. 60:45–51.